HRP20060127A2 - Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist - Google Patents
Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonistInfo
- Publication number
- HRP20060127A2 HRP20060127A2 HR20060127A HRP20060127A HRP20060127A2 HR P20060127 A2 HRP20060127 A2 HR P20060127A2 HR 20060127 A HR20060127 A HR 20060127A HR P20060127 A HRP20060127 A HR P20060127A HR P20060127 A2 HRP20060127 A2 HR P20060127A2
- Authority
- HR
- Croatia
- Prior art keywords
- arylindenopyridines
- adenosine
- receptor antagonist
- pharmaceutical compositions
- arylindenopyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/031471 WO2005042500A1 (en) | 2003-10-03 | 2003-10-03 | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20060127A2 true HRP20060127A2 (en) | 2006-07-31 |
Family
ID=34548801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20060127A HRP20060127A2 (en) | 2003-10-03 | 2006-03-30 | Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1673354B1 (es) |
| JP (1) | JP4725963B2 (es) |
| CN (1) | CN1878761A (es) |
| AT (1) | ATE429421T1 (es) |
| AU (1) | AU2003275430A1 (es) |
| BR (1) | BR0318521A (es) |
| CA (1) | CA2540686A1 (es) |
| CY (1) | CY1109808T1 (es) |
| DE (1) | DE60327375D1 (es) |
| DK (1) | DK1673354T3 (es) |
| EA (1) | EA200600688A1 (es) |
| EC (1) | ECSP066474A (es) |
| ES (1) | ES2326075T3 (es) |
| HK (1) | HK1091200A1 (es) |
| HR (1) | HRP20060127A2 (es) |
| IL (1) | IL174678A0 (es) |
| IS (1) | IS8377A (es) |
| NO (1) | NO20061981L (es) |
| PT (1) | PT1673354E (es) |
| RS (1) | RS20060237A (es) |
| SI (1) | SI1673354T1 (es) |
| WO (1) | WO2005042500A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| EP2040549B1 (en) | 2006-07-11 | 2013-10-23 | Janssen Pharmaceutica NV | Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| US7985745B2 (en) | 2006-10-02 | 2011-07-26 | Abbott Laboratories | Method for pain treatment |
| US8735411B2 (en) | 2006-10-02 | 2014-05-27 | Abbvie Inc. | Macrocyclic benzofused pyrimidine derivatives |
| US7960400B2 (en) | 2007-08-27 | 2011-06-14 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| EP2217575A1 (en) | 2007-10-24 | 2010-08-18 | Janssen Pharmaceutica, N.V. | Arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| PA8801401A1 (es) * | 2007-10-25 | 2009-05-15 | Janssen Pharmaceutica Nv | Arilindenopirimidinas y su uso como adenosina a2a |
| US20100093763A1 (en) * | 2008-10-13 | 2010-04-15 | Barbay J Kent | PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| US20110105494A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| US20110105492A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| US20110105541A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| US20110105540A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | 2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST |
| US20110105493A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| AR103992A1 (es) | 2015-01-16 | 2017-06-21 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Método para preparar compuestos fenólicos a partir de biomasa |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993008167A1 (en) * | 1991-10-24 | 1993-04-29 | Nippon Soda Co., Ltd. | Novel heterocyclic derivative and agrohorticultural bactericide containing same |
| ATE174591T1 (de) * | 1993-09-15 | 1999-01-15 | Merck Sharp & Dohme | Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor- subtyps |
| JP2001139556A (ja) * | 1999-03-18 | 2001-05-22 | Nippon Soda Co Ltd | インデノピリジンおよびインデノピリミジン化合物並びにその製造法 |
| KR100521735B1 (ko) * | 2000-02-25 | 2005-10-17 | 에프. 호프만-라 로슈 아게 | 아데노신 수용체 조절인자 |
| CA2445188A1 (en) * | 2001-04-18 | 2002-10-31 | Ortho-Mcneil Pharmaceutical, Inc. | Arylindenopyridines with pde inhibiting activity |
| US6958328B2 (en) * | 2001-04-18 | 2005-10-25 | Ortho-Mcneil Pharmaceutical, Inc | Arylindenopyridines and related therapeutic and prophylactic methods |
-
2003
- 2003-10-03 SI SI200331625T patent/SI1673354T1/sl unknown
- 2003-10-03 ES ES03759708T patent/ES2326075T3/es not_active Expired - Lifetime
- 2003-10-03 BR BRPI0318521-4A patent/BR0318521A/pt not_active IP Right Cessation
- 2003-10-03 EA EA200600688A patent/EA200600688A1/ru unknown
- 2003-10-03 JP JP2005510193A patent/JP4725963B2/ja not_active Expired - Fee Related
- 2003-10-03 DE DE60327375T patent/DE60327375D1/de not_active Expired - Lifetime
- 2003-10-03 WO PCT/US2003/031471 patent/WO2005042500A1/en active Application Filing
- 2003-10-03 RS YUP-2006/0237A patent/RS20060237A/sr unknown
- 2003-10-03 CN CNA2003801107612A patent/CN1878761A/zh active Pending
- 2003-10-03 CA CA002540686A patent/CA2540686A1/en not_active Abandoned
- 2003-10-03 DK DK03759708T patent/DK1673354T3/da active
- 2003-10-03 EP EP03759708A patent/EP1673354B1/en not_active Expired - Lifetime
- 2003-10-03 AU AU2003275430A patent/AU2003275430A1/en not_active Abandoned
- 2003-10-03 PT PT03759708T patent/PT1673354E/pt unknown
- 2003-10-03 AT AT03759708T patent/ATE429421T1/de active
-
2006
- 2006-03-27 IS IS8377A patent/IS8377A/is unknown
- 2006-03-30 IL IL174678A patent/IL174678A0/en unknown
- 2006-03-30 HR HR20060127A patent/HRP20060127A2/xx not_active Application Discontinuation
- 2006-04-03 EC EC2006006474A patent/ECSP066474A/es unknown
- 2006-05-03 NO NO20061981A patent/NO20061981L/no not_active Application Discontinuation
- 2006-10-25 HK HK06111781.4A patent/HK1091200A1/xx not_active IP Right Cessation
-
2009
- 2009-07-14 CY CY20091100752T patent/CY1109808T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2326075T3 (es) | 2009-09-30 |
| CA2540686A1 (en) | 2005-05-12 |
| BR0318521A (pt) | 2006-09-12 |
| DK1673354T3 (da) | 2009-07-27 |
| EP1673354A1 (en) | 2006-06-28 |
| ECSP066474A (es) | 2006-10-10 |
| IL174678A0 (en) | 2006-08-20 |
| HK1091200A1 (en) | 2007-01-12 |
| AU2003275430A1 (en) | 2005-05-19 |
| EA200600688A1 (ru) | 2006-10-27 |
| JP2007521243A (ja) | 2007-08-02 |
| IS8377A (is) | 2006-03-27 |
| RS20060237A (en) | 2008-11-28 |
| SI1673354T1 (sl) | 2009-10-31 |
| EP1673354B1 (en) | 2009-04-22 |
| JP4725963B2 (ja) | 2011-07-13 |
| DE60327375D1 (de) | 2009-06-04 |
| WO2005042500A1 (en) | 2005-05-12 |
| CY1109808T1 (el) | 2014-09-10 |
| NO20061981L (no) | 2006-07-03 |
| ATE429421T1 (de) | 2009-05-15 |
| PT1673354E (pt) | 2009-07-14 |
| CN1878761A (zh) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL174678A0 (en) | Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist | |
| HK1098460A1 (en) | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders | |
| MXPA05012025A (es) | Imidazo y tiazolopiridinas como inhibidores de cinasa jak3. | |
| UA83659C2 (ru) | Антагонисты рецепторов p2x7 и их применение, фармацевтическая композиция на их основе, способ их получения (варианты) | |
| WO2006011050A3 (en) | Pyridine derivatives | |
| MXPA05010859A (es) | Antagonistas mchr1 heterociclicos. | |
| TW200720260A (en) | Prokineticin 1 receptor antagonists | |
| HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| MXPA06003363A (es) | Derivados de fenil-piperazina como moduladores de receptores muscarinicos. | |
| MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
| TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
| TW200514781A (en) | Novel compounds | |
| RS20050450A (en) | 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists | |
| DE602004005960D1 (de) | Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten | |
| EP1617806A4 (en) | SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| WO2003076426A3 (en) | Pyridinyloxy derivatives as 5-ht receptor ligands | |
| ATE316972T1 (de) | Trizyklische crf rezeptor antagonisten | |
| MXPA05006587A (es) | Compuestos de tiazol como derivados de antagonistas del receptor de la integrina. | |
| DK1373218T3 (da) | Imidazolylderivater til anvendelse som histamin H3-receptorligander | |
| TW200504074A (en) | 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto | |
| UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110929 Year of fee payment: 9 |
|
| OBST | Application withdrawn |